|
1
|
Frazier Life Sciences Management
Palo Alto,
California
|
$93.2M
|
+$24.6M
|
+2,579,737
|
+44%
|
|
|
2
|
Medicxi Ventures Management
St. Helier,
Jersey
|
$27.5M
|
+$320K
|
+33,595
|
+1%
|
|
|
3
|
Deerfield Management
New York
|
$26.8M
|
+$23M
|
+2,414,897
|
New
|
|
|
4
|
|
$22.9M
|
+$201K
|
+21,062
|
+1%
|
|
|
5
|
Avidity Partners Management
Dallas,
Texas
|
$21.1M
|
-$124K
|
-13,000
|
-0.7%
|
|
|
6
|
Ensign Peak Advisors
Salt Lake City,
Utah
|
$19.5M
|
+$817K
|
+85,703
|
+5%
|
|
|
7
|
683 Capital Management
New York
|
$18.4M
|
+$2.13M
|
+223,943
|
+16%
|
|
|
8
|
|
$17.1M
|
-$330K
|
-34,587
|
-2%
|
|
|
9
|
Abingworth
London,
United Kingdom
|
$15.9M
|
–
|
–
|
–
|
|
|
10
|
Vanguard Group
Malvern,
Pennsylvania
|
$10.7M
|
-$8.72M
|
-915,098
|
-49%
|
|
|
11
|
GW&K Investment Management
Boston,
Massachusetts
|
$6.57M
|
+$950K
|
+99,709
|
+20%
|
|
|
12
|
Gilder Gagnon Howe & Co
New York
|
$6.12M
|
-$34.9K
|
-3,663
|
-0.7%
|
|
|
13
|
State Street
Boston,
Massachusetts
|
$4.94M
|
+$349K
|
+36,613
|
+9%
|
|
|
14
|
StepStone Group
La Jolla,
California
|
$4.68M
|
–
|
–
|
–
|
|
|
15
|
Geode Capital Management
Boston,
Massachusetts
|
$4.46M
|
+$527K
|
+55,356
|
+16%
|
|
|
16
|
Newtyn Management
New York
|
$3.5M
|
+$574K
|
+60,208
|
+24%
|
|
|
17
|
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
$2.49M
|
–
|
–
|
–
|
|
|
18
|
Rothschild & Co Asset Management US
Stamford,
Connecticut
|
$2.3M
|
+$66.7K
|
+7,005
|
+3%
|
|
|
19
|
MPM BioImpact
Boston,
Massachusetts
|
$2.14M
|
–
|
–
|
–
|
|
|
20
|
Northern Trust
Chicago,
Illinois
|
$2.12M
|
+$17.4K
|
+1,821
|
+1%
|
|
|
21
|
|
$1.9M
|
+$5.55K
|
+583
|
+0.3%
|
|
|
22
|
Charles Schwab
San Francisco,
California
|
$1.74M
|
+$351K
|
+36,866
|
+31%
|
|
|
23
|
UBS O'Connor
Chicago,
Illinois
|
$1.71M
|
+$257K
|
+27,000
|
+21%
|
|
|
24
|
Nuveen
Charlotte,
North Carolina
|
$1.3M
|
+$19.4K
|
+2,036
|
+2%
|
|
|
25
|
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
$1.24M
|
+$1.07M
|
+112,035
|
New
|
|
